IFAM
AVEO

Institutional & Family Asset Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Institutional & Family Asset Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-50
Closed -$1K – 898
2018
Q1 		$1K Buy
+50
New +$1.46K ﹤0.01% 832

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Institutional & Family Asset Management's AVEO Position: Q2 2018 in Review

Institutional & Family Asset Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2018, closing a stake of 50 shares — an estimated $1K sold.

Institutional & Family Asset Management first reported a position in AVEO in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 94 funds tracked by Wall St. Rank hold AVEO as of Q2 2018.

  • Institutional & Family Asset Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Institutional & Family Asset Management sold 50 AVEO Pharmaceuticals, Inc. shares in Q2 2018, an estimated $1K.
  • Institutional & Family Asset Management first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2018 and held it in 1 quarter.
  • Institutional & Family Asset Management's AVEO Pharmaceuticals, Inc. position peaked at $1K in Q1 2018.
  • 94 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2018.

Based on Institutional & Family Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.